Overview of Dr. Kline
Dr. Justin Kline is an oncologist in Chicago, IL and is affiliated with University of Chicago Medical Center. He received his medical degree from University of Chicago Pritzker School of Medicine and has been in practice 16 years. He specializes in hematologic oncology and is experienced in hematologic oncology and stem cell transplantation.
Office
5841 S. MARYLAND
M/C 2115
Chicago, IL 60637Fax+1 773-702-9268- Is this information wrong?
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 2004 - 2007- University of ChicagoResidency, Internal Medicine, 2001 - 2004
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2001
Certifications & Licensure
IL State Medical License 2001 - 2023- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Stem Cell Transplantation for Patients With Multiple Myeloma Start of enrollment: 2011 Jul 12
- Pembrolizumab for Patients With PD-L1 Diffuse Large B Cell Lymphoma (DLBCL) Start of enrollment: 2023 Aug 02
- Pembrolizumab in Combination With Chemotherapy for Patients With Untreated B Cell Lymphoma Start of enrollment: 2019 Aug 29
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsT-cell States, Repertoire, and Function in Classical Hodgkin Lymphoma Revealed through Single-Cell Analyses.Chen, X., Chen, M., Cooper, A., Tumuluru, S., Yu, J., Venkataraman, G., Smith, S., Brody, J., Godfrey, J., Kline, J.> ;Cancer Immunology Research. 2024 Mar 4
- CD5 Gene Signature Identifies Diffuse Large B-Cell Lymphomas Sensitive to Bruton's Tyrosine Kinase Inhibition.Cooper, A., Tumuluru, S., Kissick, K., Venkataraman, G., Song, J., Lytle, A., Duns, G., Yu, J., Kotlov, N., Bagaev, A., Hodkinson, B., Srinivasan, S., Smith, S., Scott...> ;Journal of Clinical Oncology. 2024 Feb 1
- A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma.Reid W Merryman, Robert A Redd, Arnold S Freedman, Inhye E Ahn, Jennifer R Brown, Jennifer L Crombie, Matthew S Davids, David C Fisher, Eric D Jacobsen, Austin I Kim, ...> ;Annals of Hematology. 2024 Jan 1
- Join now to see all
Journal Articles
- CD8α+ Dendritic Cells Dictate Leukemia-Specific CD8+ T Cell FatesJustin Kline, MD, The Journal of Immunology
- CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s LymphomaMark P Chao, Sonali M Smith, Ranjana Advani, Ian Flinn, Ravindra Majeti, Nancy L Bartlett, Leslie Popplewell, Justin Kline, Nilanjan Ghosh, Ann LaCasce, The New England Journal of Medicine
Abstracts/Posters
- Integrative Immunogenomic Characterization of Diffuse Large B-Cell Lymphoma (DLBCL) Identifies Four Molecular Subtypes with Distinct Immune LandscapesJustin Kline, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Beyond PD-1: Investigating the Therapeutic Potential of TIGIT Blockade in DLBCLJustin Kline, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Feasibility and Outcomes of T-Cell Depleted Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory AML and High Risk MDSJustin Kline, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Axicabtagene Ciloleucel in the Real World: Outcomes and Predictors of Response, Resistance and Toxicity2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Nivolumab Combined with Brentuximab Vedotin for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma: Preliminary Results from the Phase 2 CheckMate 436 Trial2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Emerging Role of Immune Checkpoint Blockade in the Treatment of Refractory/Relapsed Hodgkin and Non-Hodgkin Lymphoma60th American Society of Hematology Annual Meeting - 11/30/2018
Press Mentions
ASCO Annual Meeting Returns to Chicago, Celebrates New Progress in CancerJune 15th, 2022- New Analysis of the Tumor Microenvironment Reveals 3 Subtypes in Large B-cell Lymphoma of the BrainSeptember 28th, 2020
‘Encouraging’ Responses Seen with Durvalumab plus R-CHOP in DLBCLJune 17th, 2019- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
University of Chicago Medical CenterChicago, Illinois
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Illinois BlueChoice Select
BCBS Illinois PPO
BCBS North Carolina BlueOptions PPO
Blue Shield California PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Cofinity PPO
Coventry Health Care PPO PlatinumCoventry Missouri - HMO/POS
First Health PPO
Great West PPO
Health Net California Large Group PPO
HealthLink PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
Sagamore Health Plus
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
